Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol "FAVOR"

Active, not recruiting

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Age ≥ 30 years old
- Acute ischemic stroke patient who has corresponding DWI(diffusion- weighted imaging) lesion correlated with symptom
- after 7days, but within 28days from stroke onset
- Diagnosed with Hypertension
- hypertensive patients who taking anti-hypertensive drugs or SBP≥140mmHg
- Informed consent

Exclusion Criteria

- Patients with hemorrhagic Stroke
- Patients with severe Stroke - over NIHss(National Institutes of Health stroke scale) 16
- Uncontrolled hypertension (SBP ≥200mmHg)
- Patients with history of allergic reaction to any angiotensin II antagonist
- Liver disease(more than double to normal level, SGOT(serum glutamic-oxaloacetic transaminase ), SGPT(serum glutamic-pyruvic transaminase ), total bilirubin)
- Renal disease(serum creatinine ≥2.0mg/dl)
- Anemia(Hb < 8mg/dl)
- Thrombocytopenia( < 10^3/ml)
- Patients with secondary hypertension
- Childbearing and breast-feeding women
- Otherwise inappropriate patients depending on the investigator's decision